Giulia C. Kennedy, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 28,570 shares at $55.78 ($1.6M) on 2020-12-04, disclosed to the SEC on 2020-12-04.
Open-market sale of $1.6M VCYT by Chief Scientific & Med Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.08 | 540 | $30K | 1.8% |
| 2 | $55.78 | 3,642 | $203K | 12.5% |
| 3 | $55.78 | 3,642 | $203K | 12.5% |
| 4 | $56.86 | 4,279 | $243K | 15.0% |
| 5 | $56.86 | 4,279 | $243K | 15.0% |
| 6 | $57.55 | 6,094 |
| $351K |
| 21.6% |
| 7 | $57.55 | 6,094 | $351K | 21.6% |
| Total | $56.85 avg | 28,570 | $1.6M | 100% |
| Filing → |
| VCYT | SELL | 2022-11-08 | $26K | — | Filing → |
| VCYT | SELL | 2022-08-09 | $27K | — | Filing → |
| VCYT | SELL | 2022-03-09 | $1.0M | — | Filing → |